Podophyllum resin

Podophyllum resin
Clinical data
Trade names	Podocon-25, others
AHFS/Drugs.com	Monograph
ATC code	D06BB04 (WHO) ;
Identifiers
CAS Number	9000-55-9;
ChemSpider	none;
UNII	16902YVY2B;
ECHA InfoCard	100.029.575

Podophyllum resin, also known as podophyllum or podophyllin, is a resin made from the roots of the American mandrake.^[1] It is used as a medication to treat genital warts and plantar warts, including in people with HIV/AIDS.^[2]^[3] It is not recommended in HPV infections without external warts. Application by a healthcare provider to the skin is recommended.^[2]

Common side effects include redness, itchiness, and pain at the site of use. Severe side effects may include vomiting, abdominal pain, confusion, bone marrow suppression, and diarrhea. It is not recommended for more than a small area at a time. Use during pregnancy is known to be dangerous to the baby.^[2] It works mostly via podophyllotoxin which stops cell division.^[1]

Podophyllin resin has been used to treat warts since at least 1820.^[4] It is on the World Health Organization's List of Essential Medicines.^[5]^[6] A formulation known as podophyllotoxin with less side effects is also available.^[3]

References

^ a b Briggs GG, Freeman RK, Yaffe SJ (2011). Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk. Lippincott Williams & Wilkins. p. 1190. ISBN 9781608317080. Archived from the original on 22 December 2016.
^ a b c "Podophyllum Resin". The American Society of Health-System Pharmacists. Archived from the original on 22 December 2016. Retrieved 8 December 2016.
^ a b World Health Organization (2009). Stuart MC, Kouimtzi M, Hill SR (eds.). WHO Model Formulary 2008. World Health Organization. pp. 307, 309. hdl:10665/44053. ISBN 9789241547659.
^ Lata H, Chandra S (2010). "Biotechnological characterization of different populations of an endangered medicinal herb - Podophyllum hexandrum Royle". In Arora R (ed.). Medicinal plant biotechnology. CABI. p. 36. doi:10.1079/9781845936785.0036. ISBN 9781845936921.
^ World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
^ World Health Organization (2021). World Health Organization model list of essential medicines: 22nd list (2021). Geneva: World Health Organization. hdl:10665/345533. WHO/MHP/HPS/EML/2021.02.

[Bri2011-1] Briggs GG, Freeman RK, Yaffe SJ (2011). Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk. Lippincott Williams & Wilkins. p. 1190. ISBN 9781608317080. Archived from the original on 22 December 2016.

[AHFS2016-2] "Podophyllum Resin". The American Society of Health-System Pharmacists. Archived from the original on 22 December 2016. Retrieved 8 December 2016.

[WHO2008-3] World Health Organization (2009). Stuart MC, Kouimtzi M, Hill SR (eds.). WHO Model Formulary 2008. World Health Organization. pp. 307, 309. hdl:10665/44053. ISBN 9789241547659.

[4] Lata H, Chandra S (2010). "Biotechnological characterization of different populations of an endangered medicinal herb - Podophyllum hexandrum Royle". In Arora R (ed.). Medicinal plant biotechnology. CABI. p. 36. doi:10.1079/9781845936785.0036. ISBN 9781845936921.

[WHO21st-5] World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.

[WHO22nd-6] World Health Organization (2021). World Health Organization model list of essential medicines: 22nd list (2021). Geneva: World Health Organization. hdl:10665/345533. WHO/MHP/HPS/EML/2021.02.